Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive (Q70989566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

M A Maggard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

E A Catlin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P L Hudson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P K Donahoe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D T MacLaughlin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

190-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

Source of the anti-Müllerian hormone synthesized by the fetal testis: Müllerian-inhibiting activity of fetal bovine Sertoli cells in tissue culture.

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Mullerian inhibiting substance fractionation by dye affinity chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Müllerian Inhibiting Substance Activity in Bovine Fetal, Newborn and Prepubertal Testes1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Production of Anti-Müllerian Hormone: Another Homology between Sertoli and Granulosa Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Müllerian inhibiting substance as oocyte meiosis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Müllerian Duct Regression in the Embryo Correlated with Cytotoxic Activity Against Human Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Müllerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Identification of a receptor for human müllerian inhibiting substance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

A dual receptor system is required for basic fibroblast growth factor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

Phosphorylation events during Müllerian duct regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990052-9

10.1016/S0026-0495(96)90052-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8596488%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference